Sun Jun
Department of Medicine, Gastroenterology & Hepatology Division and Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Ave., Rochester, New York 14642, USA.
Antiinflamm Antiallergy Agents Med Chem. 2009 Sep 1;8(3):214-227. doi: 10.2174/187152309789151986.
Bacteria use multiple strategies to bypass the inflammatory responses in order to survive in the host cells. In this review, we discuss the mechanism of the bacerial proteins in inhibiting inflammation. We highlight the anti-inflammatory roles of the type three secretion proteins including Salmonella AvrA, Enteropathogenic Escherichia coli Cif, and Yersinia YopJ, Staphylococcus aureus extracellular adherence protein, and Chlamydia proteins. We also discuss the research progress on the structures of these anti-inflammatory bacterial proteins. The current therapeutic methods for diseases, such as inflammatory bowel diseases, sclerosis, lack influence on the course of chronic inflammation and infection. Therefore, based on the molecular mechanism of the anti-inflammatory bacterial proteins and their 3-Dimension structure, we can design new peptides or non-peptidic molecules that serve as anti-inflammatory drugs without the possible side effect of promoting bacterial infection.
细菌采用多种策略来绕过炎症反应,以便在宿主细胞中存活。在本综述中,我们讨论了细菌蛋白抑制炎症的机制。我们重点介绍了三种分泌蛋白的抗炎作用,包括沙门氏菌AvrA、肠致病性大肠杆菌Cif、耶尔森氏菌YopJ、金黄色葡萄球菌细胞外粘附蛋白和衣原体蛋白。我们还讨论了这些抗炎细菌蛋白结构的研究进展。目前针对诸如炎症性肠病、硬化症等疾病的治疗方法,对慢性炎症和感染的病程缺乏影响。因此,基于抗炎细菌蛋白的分子机制及其三维结构,我们可以设计出新的肽或非肽类分子作为抗炎药物,而不会有促进细菌感染的潜在副作用。